With 28 member states and associated countries, initiating a clinical trial in the EU is perceived by many in the industry to be a daunting challenge. Upcoming changes in the regulations will change the clinical trial approval process, and make it much easier for pharma and biotech companies.
Objectives of the session:
- Understand the current scenario for including European site(s) in your clinical trials;
- Anticipate and plan for future changes and their impact on the overall approval process and timeline.
Access the full webinar replay now
Fill in the form to download the content
All our resources 
